PlainRecalls
FDA Drug Low Class III Terminated

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.

Reported: June 10, 2020 Initiated: May 28, 2020 #D-1289-2020

Product Description

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.

Reason for Recall

Presence of Foreign Substance consistent with granules from desiccant packs used during storage

Details

Recalling Firm
AVKARE Inc.
Units Affected
4124 bottles
Distribution
Nationwide in the U.S.
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.. Recalled by AVKARE Inc.. Units affected: 4124 bottles.
Why was this product recalled?
Presence of Foreign Substance consistent with granules from desiccant packs used during storage
Which agency issued this recall?
This recall was issued by the FDA Drug on June 10, 2020. Severity: Low. Recall number: D-1289-2020.